Literature DB >> 24402233

[Trends of work force participation of patients with rheumatic diseases : results from German social insurance data and the national database of the German collaborative arthritis centers].

W Mau1, K Thiele, J Lamprecht.   

Abstract

Positive therapeutic effects on the work force participation derived from international clinical trials may not be directly transferable to the community based care in Germany. Therefore recent changes of data regarding sick leave (SL), work disability pension (WDP) and employment from the social insurance and from the national database of the German collaborative arthritis centers were analyzed covering a time period of at least 10 years. Health insurance data showed a steeper decline in the average duration of SL caused by rheumatoid arthritis (RA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE) compared with all other diseases. In RA patients from the collaborative arthritis centers the mean duration of SL was much more reduced than the average duration of SL for members of the compulsory health insurance. The proportion of gainfully employed RA patients in collaborative arthritis centers has particularly increased in women. According to data from the pension insurance fund less incident cases of WDP due to RA, AS, and SLE have been observed than WDP caused by all other diseases. Thus different nationwide data show positive changes of the work force participation of individuals suffering from inflammatory rheumatic diseases in Germany.

Entities:  

Mesh:

Year:  2014        PMID: 24402233     DOI: 10.1007/s00393-013-1205-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  8 in total

1.  The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents.

Authors:  Eva Hallert; Magnus Husberg; Lars Bernfort
Journal:  Rheumatology (Oxford)       Date:  2011-11-16       Impact factor: 7.580

2.  Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

Authors:  Wilfried Mau; Joachim Listing; Doerte Huscher; Henning Zeidler; Angela Zink
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

Review 3.  [Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany].

Authors:  W Mau; W Beyer; I Ehlebracht-König; M Engel; E Genth; B Greitemann; W H Jäckel; A Zink
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

4.  Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres.

Authors:  Stefanie Ziegler; Dörte Huscher; Kirsten Karberg; Andreas Krause; Siegfried Wassenberg; Angela Zink
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

5.  Platonic outcomes.

Authors:  J F Fries; D R Ramey
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

6.  [Long-term follow-up and prognosis of work capacity in the early stage of chronic polyarthritis].

Authors:  W Bräuer; S Merkesdal; W Mau
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

Review 7.  The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review.

Authors:  M M ter Wee; W F Lems; H Usan; A Gulpen; A Boonen
Journal:  Ann Rheum Dis       Date:  2011-10-13       Impact factor: 19.103

8.  Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.

Authors:  D Huscher; S Merkesdal; K Thiele; H Zeidler; M Schneider; A Zink
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

  8 in total
  9 in total

1.  [Trends in rehabilitation of patients with rheumatic diseases in Germany].

Authors:  W Mau; W Beyer; I Ehlebracht-König; J-M Engel; E Genth; W H Jäckel; U Lange; K Thiele
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 2.  [Physical therapy options in rheumatic diseases: what is evidence-based?]

Authors:  U Lange; S Rehart
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

Review 3.  [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].

Authors:  K Albrecht; J Callhoff; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 4.  [New antirheumatics : Advances for patients and society].

Authors:  S Throm; R Hömke
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

5.  [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

Authors:  A Zink; J Braun; E Gromnica-Ihle; D Krause; H J Lakomek; W Mau; U Müller-Ladner; J Rautenstrauch; C Specker; M Schneider
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

6.  [Treat to participation : Position paper of the German Society for Rheumatology on sustained improvement of functional health of patients with rheumatic and musculoskeletal diseases].

Authors:  W Mau; W Beyer; I Ehlebracht-König; J-M Engel; E Genth; U Lange
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

7.  Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000s.

Authors:  Katinka Albrecht; Dörte Huscher; Jutta Richter; Marina Backhaus; Sascha Bischoff; Ina Kötter; Katja Thiele; Angela Zink
Journal:  Lupus Sci Med       Date:  2014-12-12

8.  Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012.

Authors:  Dörte Huscher; Katja Thiele; Martin Rudwaleit; Katinka Charlotte Albrecht; Sascha Bischoff; Andreas Krause; Kirsten Karberg; Siegfried Wassenberg; Angela Zink
Journal:  RMD Open       Date:  2015-05-25

9.  Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy.

Authors:  Johanna Callhoff; Katinka Albrecht; Georg Schett; Angela Zink; Gisela Westhoff
Journal:  RMD Open       Date:  2015-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.